UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

Characteristics of Patients with Breast Cancer (BC) Brain Metastases (BM): Are There Any Clues for Earlier BM Diagnostic Strategies?

Annals of oncology, 2013-05, Vol.24, p.iii29

2013

Link zum Volltext

Verfügbarkeit prüfen

Her 2 3+ Locally Advanced Breast Cancer and Brain Metastases

Annals of oncology, 2014-05, Vol.25, p.i8-i8

2014

Link zum Volltext

Verfügbarkeit prüfen

Our experience with COVID-19 infection in oncology patients

Breast (Edinburgh), 2021-04, Vol.56, p.S89-S89

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term trastuzumab treatment in HER2 positive metastatic breast cancer

Breast (Edinburgh), 2021-04, Vol.56, p.S82-S83

2021

Link zum Volltext

Verfügbarkeit prüfen

Histology and molecular characteristics of pregnancy associated breast cancer

Annals of oncology, 2015-05, Vol.26, p.iii15-iii15

2015

Link zum Volltext

Verfügbarkeit prüfen

HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib

Annals of oncology, 2019-05, Vol.30, p.iii25-iii25

2019

Link zum Volltext

Verfügbarkeit prüfen

74 Breast Cancers as a Secondary Malignancy After Treatment for Hodgkin Lymphoma – Focus on HER2 Status

European journal of cancer (1990), 2012-03, Vol.48, p.S62-S62

2012

Link zum Volltext

Verfügbarkeit prüfen

Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients?

Journal of B.U. ON., 2012-04, Vol.17 (2), p.249-253

2012

Link zum Volltext

Verfügbarkeit prüfen

5077 POSTER Inflammatory Breast Cancer (IBC): Does the Confirmation of Dermal Lymphatic Invasion (DLI) Predict the Worst Outcome?

European journal of cancer (1990), 2011, Vol.47, p.S353-S353

2011

Link zum Volltext

Verfügbarkeit prüfen

HER2 status of breast carcinoma developed as a secondary malignancy after Hodgkin lymphoma treatment

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e21112-e21112

2010

Link zum Volltext

Verfügbarkeit prüfen

877: Changes of the white blood cells subsets in HER2 positive breast cancer patients treated with trastuzumab

European journal of cancer (1990), 2014-07, Vol.50, p.S214-S214

2014

Link zum Volltext

Verfügbarkeit prüfen

C0219: The Presence of Prothrombotic Mutations and a Higher FVIII Activity Contribute to Thrombosis Development During the Breast Cancer Treatment

Thrombosis research, 2014-05, Vol.133, p.S103-S103

2014

Link zum Volltext

Verfügbarkeit prüfen

19P LUNG CANCER AS A SECOND MALIGNANCY AFTER INITIAL TREATMENT OF PRIMARY NON LUNG CANCER – A SINGLE INSTITUTION EXPERIENCE

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S8-S8

2013

Link zum Volltext

Verfügbarkeit prüfen

5105 POSTER Assessing the Cognitive Function Among the Breast Cancer Patient After Chemotherapy Treatment

European journal of cancer (1990), 2011, Vol.47, p.S361-S362

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of hormone receptor and HER2 status in resected brain metastases and primary breast cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1117-1117

2010

Link zum Volltext

Verfügbarkeit prüfen

PO34 Clinico-pathologic features of young breast cancer patients treated at the Institute for Oncology and Radiology of Serbia

Breast (Edinburgh), 2014-11, Vol.23, p.S13-S14

2014

Link zum Volltext

Verfügbarkeit prüfen

Late relapse in triple negative breast cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e12022-e12022

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer

Journal of B.U. ON., 2013-10, Vol.18 (4), p.859-865

2013

Link zum Volltext

Verfügbarkeit prüfen

Fluoropyrimidine therapy : hyperbilirubinemia as a consequence of hemolysis

Cancer chemotherapy and pharmacology, 2005-12, Vol.56 (6), p.594-602

2005

Link zum Volltext

Verfügbarkeit prüfen

P.26 Evaluation of risk factors in women with breast carcinoma who developed venous thromboembolism

Thrombosis research, 2011, Vol.127, p.S135-S135

2011

Link zum Volltext

Verfügbarkeit prüfen

Brain metastases as late breast cancer relapse. Single institution experience and review of the literature

Journal of B.U. ON., 2009-04, Vol.14 (2), p.225

2009

Link zum Volltext

Verfügbarkeit prüfen

PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

Value in health, 2012-11, Vol.15 (7), p.A417-A418

2012

Link zum Volltext

Verfügbarkeit prüfen

1597P Vaccination against SARS-CoV-2 infection in patients with solid tumors: Experience from Institute for Oncology and Radiology of Serbia (IORS)

Annals of oncology, 2021-09, Vol.32, p.S1145-S1145

2021

Link zum Volltext

Verfügbarkeit prüfen

Absence of brain metastases in late relapse of HER2-overexpressed breast carcinoma

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.1014-1014

2007

Link zum Volltext

Verfügbarkeit prüfen

229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)

Annals of oncology, 2022-05, Vol.33, p.S230-S230

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(146)

Publikationsform

Artikel
(175)
Tagungsberichte
(4)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(51)
Science & Technology
(48)
Life Sciences & Biomedicine
(38)
Female
(34)
Adult
(30)
Middle Aged
(30)
Male
(25)
Aged
(24)
Oncology
(20)
Biological And Medical Sciences
(13)
Hematology, Oncology And Palliative Medicine
(13)
Treatment Outcome
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Medical Sciences
(10)
Physical Sciences
(10)
Antineoplastic Agents
(9)
Chemotherapy
(9)
Chemistry
(8)
Pharmacology. Drug Treatments
(8)
Prognosis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characteristics of Patients with Breast Cancer (BC) Brain Metastases (BM): Are There Any Clues for Earlier BM Diagnostic Strategies?

Her 2 3+ Locally Advanced Breast Cancer and Brain Metastases

Our experience with COVID-19 infection in oncology patients

Long-term trastuzumab treatment in HER2 positive metastatic breast cancer

Histology and molecular characteristics of pregnancy associated breast cancer

HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib

74 Breast Cancers as a Secondary Malignancy After Treatment for Hodgkin Lymphoma – Focus on HER2 Status

Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients?

5077 POSTER Inflammatory Breast Cancer (IBC): Does the Confirmation of Dermal Lymphatic Invasion (DLI) Predict the Worst Outcome?

HER2 status of breast carcinoma developed as a secondary malignancy after Hodgkin lymphoma treatment

877: Changes of the white blood cells subsets in HER2 positive breast cancer patients treated with trastuzumab

C0219: The Presence of Prothrombotic Mutations and a Higher FVIII Activity Contribute to Thrombosis Development During the Breast Cancer Treatment

19P LUNG CANCER AS A SECOND MALIGNANCY AFTER INITIAL TREATMENT OF PRIMARY NON LUNG CANCER – A SINGLE INSTITUTION EXPERIENCE

5105 POSTER Assessing the Cognitive Function Among the Breast Cancer Patient After Chemotherapy Treatment

Comparison of hormone receptor and HER2 status in resected brain metastases and primary breast cancer

PO34 Clinico-pathologic features of young breast cancer patients treated at the Institute for Oncology and Radiology of Serbia

Late relapse in triple negative breast cancer

Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer

Fluoropyrimidine therapy : hyperbilirubinemia as a consequence of hemolysis

P.26 Evaluation of risk factors in women with breast carcinoma who developed venous thromboembolism

Brain metastases as late breast cancer relapse. Single institution experience and review of the literature

PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

1597P Vaccination against SARS-CoV-2 infection in patients with solid tumors: Experience from Institute for Oncology and Radiology of Serbia (IORS)

Absence of brain metastases in late relapse of HER2-overexpressed breast carcinoma

229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)

Suchergebnisse filtern